Tools
ToolsSalter, Brian and Salter, Charlotte (2010) Governing innovation in the biomedicine knowledge economy: stem cell science in the USA. Science and Public Policy, 37 (2). pp. 87-100. ISSN 0302-3427
Full text not available from this repository. (Request a copy)Abstract
The burgeoning opportunities of the knowledge economy of biomedicine are matched by the governance challenges it poses to states in the pursuit of national advantage. The future markets are uncertain, the process of knowledge production from basic science to therapeutic product complex, and the possibility of failure ever present. Drawing on theories of the state, innovation and governance, this article explores the governance demands of knowledge production in biomedicine and the roles of state, regional levels of governance and private governance in the policy response. Applying the analytical framework derived from this discussion to the US case, the multi-dimensional governance of stem cell science in the arenas of science, society and the market is examined in an exploration of the USA's innovation capacity in this field.
| Item Type: | Article |
|---|---|
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care |
| Depositing User: | EPrints Services |
| Date Deposited: | 25 Nov 2010 11:13 |
| Last Modified: | 23 Oct 2022 01:17 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/15273 |
| DOI: | 10.3152/030234210X489617 |
Actions (login required)
 |
View Item |